D-0333-2026 Class II Ongoing
FDA drug recall D-0333-2026 was initiated by Fresenius Kabi Compounding, LLC on Feb 5, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 1057 bags.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 18, 2026
- Initiation Date
- Feb 5, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1057 bags
Product description
acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
US Nationwide.
Code information
Lot # C274-000049124, Exp Date: 28-Feb-26.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0333-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026